Loading...
Projects / Programmes
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 1.09.00 | Natural sciences and mathematics | Pharmacy |
| Code | Science | Field |
|---|---|---|
| 3.01 | Medical and Health Sciences | Basic medicine |
Evaluation
(metodology)
Points
4,497.04
A''
1,030.77
A'
2,699.92
A1/2
3,492.98
CI10
7,033
CImax
179
h10
44
A1
16.81
A3
0.29
Data for the last 5 years (citations for the last 10 years) on
June 24, 2026;
Data for score A3 calculation refer to period
2020-2024
Data for ARIS tenders (
04.04.2019 – Programme tender,
archive
)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
| Database | Linked records | Citations | Pure citations | Average pure citations |
|---|---|---|---|---|
| WoS | 344 | 8,093 | 6,820 | 19.83 |
| Scopus | 347 | 8,803 | 7,435 | 21.43 |
Organisations (1) , Researchers (7)
0787 University of Ljubljana, Faculty of Pharmacy
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 53656 | Pharmacy | Researcher | 2024 - 2026 | 42 | |
| 2. | 32034 | Oncology | Researcher | 2024 - 2026 | 234 | |
| 3. | 36438 | Pharmacy | Researcher | 2024 - 2026 | 288 | |
| 4. | 62029 | Pharmacy | Researcher | 2026 | 0 | |
| 5. | 30816 | Pharmacy | Head | 2024 - 2026 | 302 | |
| 6. | 52378 | Pharmacy | Researcher | 2024 - 2026 | 48 | |
| 7. | 28334 | Pharmacy | Researcher | 2024 - 2026 | 462 |